Edwards Lifesciences Corporation (EW)
NYSE
Closed
Oct 7, 2026
Day's Range
85.4952 wk Range
72.30Profile - EW - Edwards Lifesciences Corporation
Profile
Mic Code
XNYS
Sector
Healthcare
Industry
Medical Devices
Employees
16K
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and critical care monitoring. Edwards Lifesciences develops and markets transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid therapies, and surgical structural heart products used to repair or replace damaged heart valves. Its portfolio supports minimally invasive procedures designed for patients with advanced cardiovascular conditions, while its monitoring technologies help clinicians assess heart function and fluid status in surgical and intensive care settings. The company serves hospitals, heart centers, and healthcare professionals across major international markets, with products distributed in the United States, Europe, Japan, and other regions. Headquartered in Irvine, California, and founded in 1958, Edwards Lifesciences is recognized for its role in advancing specialized therapies for complex heart disease.
Profile Details
Type
Common Stock
Address
One Edwards Way
City
Irvine
State
CA
Zip
92614
Country
United States
Phone
949 250 2500
Key Executives - EW - Edwards Lifesciences Corporation
Key executives
Cross Listings - EW - Edwards Lifesciences Corporation
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
